Statins and Risk of Alzheimer’s Disease

This episode was broadcasted as a Live video to our Brain Health Revolution online community, where we engage on a daily basis to discuss the latest on brain health, have Live Q&As, Live cooking sessions, polls and more.

We discussed the latest data on statins, a common class of cholesterol lowering medication and focused on a recent systematic review and meta-analysis on the subject. Here is the link to the article:

Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies (2022)

For more reading, here are other published scientific articles on the subject:

Statins in Alzheimer’s disease (2022).

Unraveling the Paradox of Statins with Human Neurons: New Leads in Alzheimer’s Disease (2019).

Do statins prevent Alzheimer’s disease? A narrative review (2015).

Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults (2022).

Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis (2018).

Statins and Brain Health: Alzheimer’s Disease and Cerebrovascular Disease Biomarkers in Older Adults (2018).

The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia (2021).

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia? (2018).

Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly (2019).

Statins and Alzheimer’s disease. The answers have not come of age yet. (2022).

Statin therapy and risk of Alzheimer’s and age-related neurodegenerative diseases (2020).

Check out our online community: Brain Health Revolution

Follow us on social media:

Instragram: We recently changed our handle to The Brain Docs (@thebraindocs)

Facebook: Sherzai MD

Website: Sherzaimd.com

Listen on:

Meet your hosts:

Bella Jimenez

Creative Strategist

Edwin Watson

Creative Strategist

Caitlin Henderson

Creative Strategist